Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.Daiwa raised Tesla's target price to $420.Xinwangda: The subsidiary and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries. Xinwangda announced that the subsidiary Xinwangda Power and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries, and the two sides will carry out extensive and in-depth cooperation on research and development, mass production and market development of a series of new energy battery materials for solid-state batteries around their respective development strategies. The cooperation contents include the development of cathode materials for solid-state batteries, the development of electrolytes and related materials for solid-state batteries, the cooperative development of solid-state batteries and industrial cooperation.
Huichuan technology: the company has started to apply AI technology in the field of machine vision. Huichuan technology said at the performance briefing that in the field of AI: the company has started to apply AI technology in the field of machine vision, and the exploration in other fields will be carried out according to customer needs and industrial development. In the field of humanoid robots: the company is currently led by the product competitiveness center, and multi-departments cooperate to develop core components such as motors, drivers and actuator modules. The spin-off and listing of the company's subsidiary, United Power, is progressing steadily and is still in the stage of listing counseling.The number of employed people in Australia increased by 35,613 in November, and it is estimated to be 25,000.The International Finance Corporation (IFC) and HSBC signed a $1 billion trade flow arrangement for emerging markets.
Yuanda Environmental Protection: It is planned to invest in the flue gas treatment franchise project of 2× 1,000 MW units in Huainan Pingwei Power Plant Phase IV, reaching the environmental protection announcement. The franchise company, a wholly-owned subsidiary, plans to set up Pingwei Branch, build desulfurization, denitrification and dust removal facilities based on the 2× 1,000 MW units in Pingwei Power Plant Phase IV, and sign a franchise contract with Pingwei Power Plant to carry out the flue gas treatment franchise business. The static investment of the project is 641 million yuan, the dynamic investment is 662 million yuan, and the franchise period is not less than 20 years. It is estimated that the total annual profit of the project is 18.89 million yuan and the average annual net profit is 13.45 million yuan. This transaction will help Yuanda Environmental Protection to further expand its market in Anhui and surrounding areas, obtain long-term stable income and form new profit growth points.Polish Prime Minister Tusk told French President Macron that even if Russia and Ukraine cease fire, Polish troops will not enter Ukraine.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.
Strategy guide 12-14
Strategy guide 12-14